Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS‐CoV‐2 Vaccination

Read full text
Authors: Laura Fernandez Blanco, Lisan H Kuijper, L. Kummer, N. J. M. Verstegen, Amélie Bos, Mathieu Claireaux, Mariël C. Duurland, Tineke Jorritsma, M. Steenhuis, Gius Kerster, Juan J. Garcia Vallejo, Marit J. van Gils
+12 more Koos PJ van Dam, Eileen W Stalman, Luuk Wieske, Laura Boekel, G. Wolbink, Sander W. Tas, Theo Rispens, Taco W. Kuijpers, Filip Eftimov, Anja ten Brinke, S. Marieke van Ham, of T2B! Immunity Against SARS‐CoV‐2 Study Group
Cited by: 2
References: 34

Abstract

ABSTRACT In humans, the stages and dynamics of B cell development after antigen encounter remain unclear. Identifying early B cell differentiation stages could reveal biomarkers for humoral immunity and potential targets to prevent unwanted antibody responses. We characterized antigen‐specific B cell responses longitudinally after SARS‐CoV‐2 mRNA vaccination using multiparameter spectral flow cytometry. Spike‐specific IgG + CD27 + CD71 + activated B cells (ActBCs), presumed to be germinal center‐derived and IgG + DN2 extrafollicular B cells, dominated the early antigen‐specific B cell response, while memory B cells were the main population 6 months after vaccination. Within the IgG + ActBC compartment, we delineated six novel clusters with specific contraction dynamics. Following the second vaccination, certain ActBC clusters displayed sustained expansion over time, being phenotypically similar to memory B cells, while others strongly expanded and subsequently contracted. Several of the rapidly contracting ActBC clusters expressed CD11c, a defining marker for atypical B cells, suggesting a possible extrafollicular origin of these clusters. The transient presence of heterogeneous ActBC clusters was also observed for total B cells when gated in an antigen‐independent manner. Characterization of novel ActBC clusters early after antigen encounter helps delineate and dissect the complexity of B cell differentiation, which is vital for understanding unwanted B cell responses.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research T-cell and B-cell Immunology vaccines and immunoinformatics approaches

Publication details

Journal / source
European Journal of Immunology
Publisher
Wiley
Volume
56
Issue
3
Pages
e70165–e70165
Publication date
1 March 2026
Language
EN